Targeting type 2 inflammation in bullous pemphigoid: dupilumab as a game changer opens new avenues

被引:0
|
作者
Borradori, Luca [1 ]
Hertl, Michael [2 ]
机构
[1] Univ Bern, Univ Hosp Bern, Dept Dermatol, Bern, Switzerland
[2] Philipps Univ, Dept Dermatol & Allergol, Marburg, Germany
关键词
D O I
10.1093/bjd/ljae465
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:377 / 378
页数:2
相关论文
共 50 条
  • [1] Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches
    Toh, Wu Han
    Lee, Hua-En
    Chen, Chun-Bing
    FRONTIERS IN MEDICINE, 2023, 10
  • [2] Targeting ferroptosis opens new avenues in gliomas
    Wei, Yuxin
    Xu, Yang
    Sun, Qian
    Hong, Yu
    Liang, Shanwen
    Jiang, Hongxiang
    Zhang, Xinyi
    Zhang, Shenqi
    Chen, Qianxue
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (12): : 4674 - 4690
  • [3] Targeting ferroptosis opens new avenues for the development of novel therapeutics
    Sun, Shumin
    Shen, Jie
    Jiang, Jianwei
    Wang, Fudi
    Min, Junxia
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [4] Targeting ferroptosis opens new avenues for the development of novel therapeutics
    Shumin Sun
    Jie Shen
    Jianwei Jiang
    Fudi Wang
    Junxia Min
    Signal Transduction and Targeted Therapy, 8
  • [5] Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
    Zhang, Luyao
    Chen, Zihua
    Wang, Lanting
    Luo, Xiaoqun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)
    Werth, Victoria P.
    Murrell, Dedee F.
    Joly, Pascal
    Heck, Renata
    Orengo, Jamie M.
    Ardeleanu, Marius
    Hultsch, Verena
    ADVANCES IN THERAPY, 2024, 41 (12) : 4418 - 4432
  • [7] Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines
    Takamura, Saori
    Teraki, Yuichi
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : 845 - 850
  • [8] Management Of Bullous Pemphigoid with Diabetes Mellitus Type 2
    Palsapure, Pratiksha S.
    Balpande, Vaishali
    Pathade, Aniket
    Narlawar, M. S.
    Gujar, samruddhi
    INTERNATIONAL JOURNAL OF EARLY CHILDHOOD SPECIAL EDUCATION, 2022, 14 (04) : 2304 - 2307
  • [9] Role of basophils and type 2 inflammation in bullous pemphigoid pathophysiology: a comparative study of blood and blister fluid
    Su, Bintao
    Zhang, Quanhong
    Hu, Xianyong
    Xie, Bo
    Chen, Chao
    Zhao, Yan
    Liu, Zhi
    Ma, Ling
    Chen, Jinbo
    IMMUNOLOGIC RESEARCH, 2025, 73 (01)
  • [10] Dupilumab helps with COPD with type 2 inflammation
    Krome, Susanne
    PNEUMOLOGIE, 2024, 78 (05): : 290 - 290